BioSpace News Archive

Business

Pathalys Pharma Announces Executive Team Appointments

Pathalys Pharma, Inc. today announced the executive leadership team for the newly formed company. Pathalys officially launched on March 1, 2022.

March 30, 2022
·
4 min read
FDA

FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects

CartiHeal Ltd today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for its Agili-C™ implant.

March 30, 2022
·
3 min read
BioMidwest

Researchers Studying Inflammation Can Simplify Cytokine Detection with New Promega Lumit Immunoassays

Researchers studying immunity and inflammation now have a faster, easier alternative to traditional enzyme-linked immunosorbent assays (ELISAs) with new Promega bioluminescent assays launched today.

March 30, 2022
·
3 min read
BioCapital

Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023

Graybug Vision, Inc. announced a strategic update on its pipeline programs GB-102 in wet age-related macular degeneration, GB-401 in primary open-angle glaucoma, as well as its newly acquired assets in corneal disease, inherited retinal diseases, and geographic atrophy.

March 30, 2022
·
10 min read
Business

Alaunos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

Alaunos Therapeutics, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2021.

March 30, 2022
·
9 min read
Drug Development

Antios Therapeutics’ ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 1b and 2a Studies

Antios Therapeutics, Inc. today announced new data from the Phase 1b and 2a clinical trials of ATI-2173, its investigational proprietary drug candidate and the only Active Site Polymerase Inhibitor Nucleotide (ASPIN) in clinical development for HBV.

March 30, 2022
·
5 min read
Business

PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update

PolarityTE to host conference call and webcast today, March 30, 2022, at 8:30 a.m. ET.

March 30, 2022
·
18 min read
BioMidwest

Altitude Lab Announces First Cohort of Startups Close Over $50M in Seed Capital

Altitude Lab announced its first cohort of startups raised $54M in seed funding while incubating at Altitude Lab.

March 30, 2022
·
5 min read
Mapi Pharma Receives U.S. Patent Covering Methods of Suppressing or Alleviating Primary or Secondary Progressive Multiple Sclerosis with a Sustained Release Glatiramer Acetate Depot

Mapi Pharma Ltd., announced today that the company has been granted U.S. Patent No. 11,167,003 entitled: “Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems.”

March 30, 2022
·
3 min read
Drug Development

Compass Therapeutics Announces Presentation on CTX-8371, A Bispecific Antibody Targeting PD-1 and PD-L1, at the 2022 AACR Annual Meeting in New Orleans

Compass Therapeutics Inc. announced today that it will present preclinical data on CTX-8371, a next generation bispecific checkpoint inhibitor that simultaneously targets PD-1 and PD-L1 at the upcoming American Association for Cancer Research (AACR) Annual Meeting, which is being held April 8-13, 2022.

March 30, 2022
·
4 min read